Business
Innocan Pharma Reports Successful Results of Efficacy Test for Vaginal Derma Product
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - March 23, 2023) - Innocan Pharma Corpora...
About this update from Innocan Pharma Corporation
[{"type":"text","content":"Innocan Pharma Reports Successful Results of Efficacy Test for Vaginal Derma ProductHerzliya, Israel and Calgary, Alberta--(Newsfile Corp. - March 23, 2023) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the \"Company\" or \"Innocan\") a pharmaceutical technology company focusing on developing innovative wellness products, announced today the successful results of a controlled efficacy test (the \"Trial\") regarding its vaginal derma product (the \"Product\").The results of the Trial demonstrate that Innocan's Product, which contains cannabinoids, phytoestrogens, hyaluronic acid, and probiotics, effectively reduced the symptoms, and improved overall vaginal health.The 56-day Trial was conducted with a group of female volunteers experiencing symptoms of vaginal dryness, stinging, burning, infection, and pain during urination.The primary indication of the Trial was a statistically significant alleviation of symptoms after 28 days of Product use including: Percentage improvement Compared to T0Symptoms66%Vaginal burning64%Pruritus (Itching)47%Vaginal dryness59%Pain during intercourse63%Urinary discomfort Furthermore, 94% of the volunteers reported a reduction in vaginal dryness, 94% indicated better sensation during intimate relationships, and 91% stated that the vaginal area became more elastic. Additionally, 93% of the volunteers reported a reduction in discomfort during sports activity, 94% felt immediate relief from vaginal itching, 93% felt their skin was healthier, and 97% would recommend the Product to others.The Product does not contain hormones or steroids, which are commonly used to treat similar symptoms and can have negative side effects. Innocan's use of cannabinoids and other natural ingredients offers a healthy alternative for women seeking relief from vaginal discomfort.\"We are thrilled with the results of this efficacy test and the positive impact our product had on the women who participated,\" said Iris Bincovich, CEO of Innocan. \"Our focus is on developing safe and effective products that can improve the quality of life for people in need, and we are proud to achieve such promising results with our vaginal derma product.\"About InnocanInnocan is a pharmaceutical tech company that operates under two main segments: Pharmaceuticals and Consumer Wellness. In the Pharmaceuticals segment, In...